Intrinsic value of Molina Healthcare - MOH

Previous Close

$72.12

  Intrinsic Value

$147.20

stock screener

  Rating & Target

str. buy

+104%

Previous close

$72.12

 
Intrinsic value

$147.20

 
Up/down potential

+104%

 
Rating

str. buy

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of MOH stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

Please visit our new site that uses elements of artificial intelligence for stock valuation: artificial intelligence value of Molina Healthcare (MOH) stock.

STOCK VALUATION INPUT DATA

Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Shares outstanding, mln

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  25.42
  10.70
  10.13
  9.62
  9.16
  8.74
  8.37
  8.03
  7.73
  7.45
  7.21
  6.99
  6.79
  6.61
  6.45
  6.30
  6.17
  6.06
  5.95
  5.86
  5.77
  5.69
  5.62
  5.56
  5.51
  5.45
  5.41
  5.37
  5.33
  5.30
  5.27
Revenue, $m
  17,782
  19,685
  21,679
  23,764
  25,939
  28,206
  30,566
  33,020
  35,571
  38,223
  40,978
  43,841
  46,817
  49,912
  53,131
  56,480
  59,967
  63,599
  67,383
  71,329
  75,445
  79,740
  84,224
  88,908
  93,802
  98,919
  104,270
  109,867
  115,725
  121,856
  128,276
Variable operating expenses, $m
 
  19,147
  21,080
  23,101
  25,210
  27,408
  29,696
  32,075
  34,549
  37,119
  39,791
  42,505
  45,390
  48,390
  51,511
  54,758
  58,139
  61,660
  65,329
  69,154
  73,145
  77,309
  81,656
  86,197
  90,943
  95,903
  101,091
  106,518
  112,197
  118,141
  124,366
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  17,476
  19,147
  21,080
  23,101
  25,210
  27,408
  29,696
  32,075
  34,549
  37,119
  39,791
  42,505
  45,390
  48,390
  51,511
  54,758
  58,139
  61,660
  65,329
  69,154
  73,145
  77,309
  81,656
  86,197
  90,943
  95,903
  101,091
  106,518
  112,197
  118,141
  124,366
Operating income, $m
  306
  538
  599
  662
  729
  798
  870
  945
  1,022
  1,103
  1,187
  1,337
  1,427
  1,522
  1,620
  1,722
  1,828
  1,939
  2,054
  2,175
  2,300
  2,431
  2,568
  2,711
  2,860
  3,016
  3,179
  3,349
  3,528
  3,715
  3,911
EBITDA, $m
  488
  699
  769
  843
  920
  1,001
  1,085
  1,172
  1,262
  1,356
  1,454
  1,556
  1,661
  1,771
  1,885
  2,004
  2,128
  2,257
  2,391
  2,531
  2,677
  2,830
  2,989
  3,155
  3,329
  3,510
  3,700
  3,899
  4,107
  4,324
  4,552
Interest expense (income), $m
  66
  48
  -53
  -41
  -29
  -16
  -2
  12
  26
  42
  57
  74
  91
  109
  127
  146
  166
  187
  209
  231
  255
  279
  305
  332
  359
  389
  419
  451
  484
  519
  556
Earnings before tax, $m
  205
  490
  652
  704
  758
  814
  872
  933
  996
  1,062
  1,130
  1,263
  1,336
  1,413
  1,493
  1,576
  1,662
  1,752
  1,846
  1,943
  2,045
  2,152
  2,263
  2,379
  2,500
  2,627
  2,760
  2,898
  3,044
  3,196
  3,355
Tax expense, $m
  153
  132
  176
  190
  205
  220
  235
  252
  269
  287
  305
  341
  361
  382
  403
  425
  449
  473
  498
  525
  552
  581
  611
  642
  675
  709
  745
  783
  822
  863
  906
Net income, $m
  52
  358
  476
  514
  553
  594
  637
  681
  727
  775
  825
  922
  976
  1,031
  1,090
  1,150
  1,213
  1,279
  1,347
  1,419
  1,493
  1,571
  1,652
  1,737
  1,825
  1,918
  2,015
  2,116
  2,222
  2,333
  2,449

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  4,577
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  7,449
  3,179
  3,501
  3,838
  4,189
  4,555
  4,936
  5,333
  5,745
  6,173
  6,618
  7,080
  7,561
  8,061
  8,581
  9,121
  9,685
  10,271
  10,882
  11,520
  12,184
  12,878
  13,602
  14,359
  15,149
  15,975
  16,839
  17,743
  18,689
  19,680
  20,716
Adjusted assets (=assets-cash), $m
  2,872
  3,179
  3,501
  3,838
  4,189
  4,555
  4,936
  5,333
  5,745
  6,173
  6,618
  7,080
  7,561
  8,061
  8,581
  9,121
  9,685
  10,271
  10,882
  11,520
  12,184
  12,878
  13,602
  14,359
  15,149
  15,975
  16,839
  17,743
  18,689
  19,680
  20,716
Revenue / Adjusted assets
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
  6.192
Average production assets, $m
  555
  610
  672
  737
  804
  874
  948
  1,024
  1,103
  1,185
  1,270
  1,359
  1,451
  1,547
  1,647
  1,751
  1,859
  1,972
  2,089
  2,211
  2,339
  2,472
  2,611
  2,756
  2,908
  3,066
  3,232
  3,406
  3,587
  3,778
  3,977
Working capital, $m
  1,418
  -2,972
  -3,273
  -3,588
  -3,917
  -4,259
  -4,615
  -4,986
  -5,371
  -5,772
  -6,188
  -6,620
  -7,069
  -7,537
  -8,023
  -8,529
  -9,055
  -9,603
  -10,175
  -10,771
  -11,392
  -12,041
  -12,718
  -13,425
  -14,164
  -14,937
  -15,745
  -16,590
  -17,474
  -18,400
  -19,370
Total debt, $m
  1,645
  -1,294
  -1,004
  -701
  -385
  -55
  288
  644
  1,015
  1,401
  1,801
  2,217
  2,650
  3,100
  3,568
  4,054
  4,561
  5,089
  5,639
  6,213
  6,811
  7,435
  8,087
  8,768
  9,479
  10,223
  11,000
  11,814
  12,665
  13,557
  14,490
Total liabilities, $m
  5,800
  2,861
  3,151
  3,454
  3,770
  4,100
  4,443
  4,799
  5,170
  5,556
  5,956
  6,372
  6,805
  7,255
  7,723
  8,209
  8,716
  9,244
  9,794
  10,368
  10,966
  11,590
  12,242
  12,923
  13,634
  14,378
  15,155
  15,969
  16,820
  17,712
  18,645
Total equity, $m
  1,649
  318
  350
  384
  419
  456
  494
  533
  574
  617
  662
  708
  756
  806
  858
  912
  968
  1,027
  1,088
  1,152
  1,218
  1,288
  1,360
  1,436
  1,515
  1,598
  1,684
  1,774
  1,869
  1,968
  2,072
Total liabilities and equity, $m
  7,449
  3,179
  3,501
  3,838
  4,189
  4,556
  4,937
  5,332
  5,744
  6,173
  6,618
  7,080
  7,561
  8,061
  8,581
  9,121
  9,684
  10,271
  10,882
  11,520
  12,184
  12,878
  13,602
  14,359
  15,149
  15,976
  16,839
  17,743
  18,689
  19,680
  20,717
Debt-to-equity ratio
  0.998
  -4.070
  -2.870
  -1.830
  -0.920
  -0.120
  0.580
  1.210
  1.770
  2.270
  2.720
  3.130
  3.500
  3.850
  4.160
  4.440
  4.710
  4.950
  5.180
  5.390
  5.590
  5.770
  5.950
  6.110
  6.260
  6.400
  6.530
  6.660
  6.780
  6.890
  6.990
Adjusted equity ratio
  -1.019
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  52
  358
  476
  514
  553
  594
  637
  681
  727
  775
  825
  922
  976
  1,031
  1,090
  1,150
  1,213
  1,279
  1,347
  1,419
  1,493
  1,571
  1,652
  1,737
  1,825
  1,918
  2,015
  2,116
  2,222
  2,333
  2,449
Depreciation, amort., depletion, $m
  182
  160
  170
  181
  192
  203
  215
  227
  240
  253
  267
  219
  234
  250
  266
  282
  300
  318
  337
  357
  377
  399
  421
  445
  469
  495
  521
  549
  579
  609
  641
Funds from operations, $m
  1,017
  518
  646
  694
  745
  797
  851
  908
  967
  1,028
  1,092
  1,141
  1,210
  1,281
  1,355
  1,433
  1,513
  1,597
  1,684
  1,775
  1,870
  1,969
  2,073
  2,181
  2,294
  2,412
  2,536
  2,665
  2,801
  2,942
  3,090
Change in working capital, $m
  344
  -287
  -301
  -315
  -329
  -342
  -356
  -371
  -385
  -400
  -416
  -432
  -449
  -467
  -486
  -506
  -527
  -548
  -571
  -596
  -621
  -649
  -677
  -707
  -739
  -773
  -808
  -845
  -884
  -926
  -969
Cash from operations, $m
  673
  805
  947
  1,009
  1,073
  1,139
  1,208
  1,279
  1,352
  1,428
  1,508
  1,573
  1,659
  1,748
  1,841
  1,938
  2,040
  2,145
  2,256
  2,371
  2,492
  2,618
  2,750
  2,888
  3,033
  3,185
  3,344
  3,510
  3,685
  3,868
  4,060
Maintenance CAPEX, $m
  0
  -89
  -98
  -108
  -119
  -130
  -141
  -153
  -165
  -178
  -191
  -205
  -219
  -234
  -250
  -266
  -282
  -300
  -318
  -337
  -357
  -377
  -399
  -421
  -445
  -469
  -495
  -521
  -549
  -579
  -609
New CAPEX, $m
  -176
  -56
  -62
  -65
  -67
  -70
  -73
  -76
  -79
  -82
  -85
  -89
  -92
  -96
  -100
  -104
  -108
  -113
  -117
  -122
  -128
  -133
  -139
  -145
  -152
  -159
  -166
  -174
  -182
  -190
  -199
Cash from investing activities, $m
  -202
  -145
  -160
  -173
  -186
  -200
  -214
  -229
  -244
  -260
  -276
  -294
  -311
  -330
  -350
  -370
  -390
  -413
  -435
  -459
  -485
  -510
  -538
  -566
  -597
  -628
  -661
  -695
  -731
  -769
  -808
Free cash flow, $m
  471
  660
  787
  836
  887
  939
  994
  1,050
  1,108
  1,168
  1,231
  1,280
  1,348
  1,418
  1,492
  1,569
  1,649
  1,733
  1,820
  1,912
  2,008
  2,108
  2,212
  2,322
  2,437
  2,557
  2,683
  2,816
  2,954
  3,099
  3,252
Issuance/(repayment) of debt, $m
  0
  -2,467
  290
  303
  316
  330
  343
  357
  371
  385
  400
  416
  433
  450
  468
  487
  507
  528
  550
  573
  598
  624
  652
  681
  711
  744
  778
  814
  851
  891
  933
Issuance/(repurchase) of shares, $m
  18
  2,416
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  19
  -51
  290
  303
  316
  330
  343
  357
  371
  385
  400
  416
  433
  450
  468
  487
  507
  528
  550
  573
  598
  624
  652
  681
  711
  744
  778
  814
  851
  891
  933
Total cash flow (excl. dividends), $m
  490
  610
  1,077
  1,139
  1,203
  1,269
  1,337
  1,406
  1,479
  1,554
  1,632
  1,696
  1,780
  1,868
  1,960
  2,056
  2,156
  2,261
  2,370
  2,485
  2,606
  2,732
  2,864
  3,003
  3,148
  3,301
  3,461
  3,629
  3,805
  3,990
  4,185
Retained Cash Flow (-), $m
  -92
  -2,774
  -32
  -34
  -35
  -37
  -38
  -40
  -41
  -43
  -44
  -46
  -48
  -50
  -52
  -54
  -56
  -59
  -61
  -64
  -66
  -69
  -72
  -76
  -79
  -83
  -86
  -90
  -95
  -99
  -104
Prev. year cash balance distribution, $m
 
  4,105
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  1,941
  1,045
  1,106
  1,168
  1,232
  1,298
  1,367
  1,438
  1,511
  1,587
  1,650
  1,732
  1,818
  1,908
  2,002
  2,100
  2,202
  2,309
  2,422
  2,539
  2,663
  2,792
  2,927
  3,069
  3,218
  3,375
  3,539
  3,711
  3,891
  4,081
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  1,861
  956
  962
  962
  955
  942
  923
  899
  868
  832
  783
  739
  691
  641
  588
  534
  479
  425
  373
  323
  275
  232
  192
  156
  125
  98
  76
  57
  42
  31
Current shareholders' claim on cash, %
  100
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0
  50.0

Molina Healthcare, Inc. offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business. It arranges healthcare services for persons served by Medicaid, Medicare, the Children's Health Insurance Program (CHIP) and the Marketplace, and products to assist government agencies in their administration of the Medicaid program. As of December 31, 2016, the Company's Health Plans segment consisted of health plans in 12 states and the Commonwealth of Puerto Rico, and its direct delivery business. The Molina Medicaid Solutions segment provides support to state government agencies in the administration of their Medicaid programs, including business processing, information technology development, and administrative services.

FINANCIAL RATIOS  of  Molina Healthcare (MOH)

Valuation Ratios
P/E Ratio 79.1
Price to Sales 0.2
Price to Book 2.5
Price to Tangible Book
Price to Cash Flow 6.1
Price to Free Cash Flow 8.3
Growth Rates
Sales Growth Rate 25.4%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 33.3%
Cap. Spend. - 3 Yr. Gr. Rate 12.4%
Financial Strength
Quick Ratio 10
Current Ratio 0.1
LT Debt to Equity 71.1%
Total Debt to Equity 99.8%
Interest Coverage 4
Management Effectiveness
Return On Assets 1%
Ret/ On Assets - 3 Yr. Avg. 2%
Return On Total Capital 1.6%
Ret/ On T. Cap. - 3 Yr. Avg. 3.6%
Return On Equity 3.2%
Return On Equity - 3 Yr. Avg. 7%
Asset Turnover 2.5
Profitability Ratios
Gross Margin 14.2%
Gross Margin - 3 Yr. Avg. 14.8%
EBITDA Margin 2.5%
EBITDA Margin - 3 Yr. Avg. 3%
Operating Margin 1.7%
Oper. Margin - 3 Yr. Avg. 2.1%
Pre-Tax Margin 1.2%
Pre-Tax Margin - 3 Yr. Avg. 1.6%
Net Profit Margin 0.3%
Net Profit Margin - 3 Yr. Avg. 0.6%
Effective Tax Rate 74.6%
Eff/ Tax Rate - 3 Yr. Avg. 61.2%
Payout Ratio 0%

MOH stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the MOH stock intrinsic value calculation we used $17782 million for the last fiscal year's total revenue generated by Molina Healthcare. The default revenue input number comes from 2016 income statement of Molina Healthcare. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our MOH stock valuation model: a) initial revenue growth rate of 10.7% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for MOH is calculated based on our internal credit rating of Molina Healthcare, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Molina Healthcare.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of MOH stock the variable cost ratio is equal to 97.3%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for MOH stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 4.1% for Molina Healthcare.

Corporate tax rate of 27% is the nominal tax rate for Molina Healthcare. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the MOH stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for MOH are equal to 3.1%.

Life of production assets of 6.2 years is the average useful life of capital assets used in Molina Healthcare operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for MOH is equal to -15.1%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $1649 million for Molina Healthcare - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 58.033 million for Molina Healthcare is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Molina Healthcare at the current share price and the inputted number of shares is $4.2 billion.

RELATED COMPANIES Price Int.Val. Rating
CNC Centene 100.22 114.47  hold
WCG WellCare Healt 193.21 3,166.33  str.buy
AET Aetna 178.51 118.29  sell
ANTM Anthem 235.02 232.84  hold
GTS Triple-S Manag 25.48 17.67  sell
UNH UnitedHealth G 229.37 191.21  hold
MGLN Magellan Healt 97.60 452.81  str.buy
HUM Humana 269.00 160.61  sell

COMPANY NEWS

▶ 9 Stocks Moving In Monday's After-Hours Session   [Feb-12-18 06:09PM  Benzinga]
▶ Molina reports 4Q loss   [04:43PM  Associated Press]
▶ Molina Healthcare Earnings Preview   [12:14PM  Benzinga]
▶ First Eagle Starts Position in Caterpillar in 4th Quarter   [Feb-06-18 01:50PM  GuruFocus.com]
▶ 5 HMO Stocks to Continue Rewarding Investors   [Jan-22-18 02:35PM  InvestorPlace]
▶ 5 HMO Stocks to Continue Rewarding Investors   [Jan-12-18 09:31AM  Zacks]
▶ Molina to transition 95 Sacramento employees to Golden Shore Medical   [Jan-10-18 06:42PM  American City Business Journals]
▶ Molina on course to exit key NM insurance market in 2019   [02:02PM  American City Business Journals]
▶ 3 Outperformers from Health Insurance in 2017   [Jan-03-18 01:47PM  Zacks]
▶ ObamaCare Isn't Dead Yet: Enrollment Tops Soft Expectations   [05:15PM  Investor's Business Daily]
▶ Molina Healthcare Scores Relative Strength Rating Upgrade   [Nov-30-17 03:00AM  Investor's Business Daily]
▶ Stocks Already Have the Holiday Spirit   [Nov-22-17 09:15AM  Zacks]
▶ Food, Fashion, Finance Firms Among 10 To IPO   [Nov-14-17 09:12AM  Benzinga]
▶ Stocks To Watch: Molina Healthcare Sees RS Rating Jump To 90   [03:00AM  Investor's Business Daily]
▶ Molina Healthcare Sees RS Rating Rise To 72   [03:00AM  Investor's Business Daily]
▶ Molina reports 3Q loss   [Nov-02-17 04:51PM  Associated Press]
▶ Molina Healthcare Getting Closer To Key Technical Measure   [Oct-31-17 03:00AM  Investor's Business Daily]
▶ Molina Healthcare Earns Relative Strength Rating Upgrade   [Oct-26-17 03:00AM  Investor's Business Daily]
▶ Trump says Obamacare is dead   [Oct-16-17 01:01PM  MarketWatch]
▶ [$$] Major Health Insurers Anticipated End of Subsidies   [Oct-13-17 11:18PM  The Wall Street Journal]
▶ [$$] Major Health Insurers Anticipated End of Subsidies   [06:46PM  The Wall Street Journal]
▶ Potential Takeover Candidate Molina Names New CEO   [Oct-11-17 05:12PM  TheStreet.com]
▶ Molina Healthcare names Hanover Insurance's Zubretsky as CEO   [02:25PM  American City Business Journals]
▶ [$$] Molina Hires Joseph Zubretsky as New CEO   [Oct-10-17 06:53PM  The Wall Street Journal]
▶ [$$] Health Insurers Stay in ACA Despite Fears of Last-Minute Exits   [Sep-27-17 07:45PM  The Wall Street Journal]
▶ 6 Undervalued Stocks Growing Earnings   [01:05PM  GuruFocus.com]
▶ Stocks With Rising Relative Strength: Molina Healthcare   [03:00AM  Investor's Business Daily]
▶ Healthcare Reform: Insurers Feel the Pain   [12:59PM  Barrons.com]
Financial statements of MOH
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.